May 27, 2026

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Conexiant

May 27, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Conexiant

May 26, 2026

Semaglutide Reduced Nicotine Craving in Small Trial

Phase 2a trial found reduced nicotine craving and weight loss with semaglutide, but no significant between-group difference in cigarettes smoked per day.

Conexiant

May 11, 2026

Remote Diet Support Studied in Diabetes

WhatsApp-based low-carbohydrate nutrition education was linked to short-term glycemic, weight, and medication-use improvements in a small primary care trial

Conexiant

May 11, 2026

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

Conexiant

May 08, 2026

Not All Lung Bacteria Are the Enemy

Cross-disease meta-analysis also found modest associations with lung function, though findings varied by disease type

Conexiant

May 08, 2026

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

Conexiant

May 07, 2026

Infections Lead Thoracic CT Findings in SLE

Researchers characterize spectrum of pulmonary and extrathoracic involvement in systemic lupus erythematosus.

Conexiant

May 06, 2026

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

Conexiant

May 06, 2026

Preexisting Risk Drove Poststorm Events

Analysis of nearly 1.6 million veterans showed preexisting community health inequities largely explained poststorm cardiovascular and respiratory outcomes.

Conexiant